McKesson to acquire controlling stake in Florida Cancer Specialists & Research Institute’s Core Ventures

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

McKesson Corp. has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures LLC (Core Ventures). 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Cell and gene therapies are steadily becoming more available to patients, but are still facing systemic hurdles slowing widespread adoption, according to the second annual 2025 “Cell and Gene Therapy Report: Advancing the Future of Medicine,” published by InspiroGene by McKesson. The report draws on new insights from research with physicians and payers, an updated...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login